Saiqa Mullick
Saiqa Mullick has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
D Watson-Jones
London School of Hygiene and Tropical Medicine, London, UK and African Medical and Research Foundation, Mwanza, Tanzania
1 shared publication- David Mabey
London School of Hygiene and Tropical Medicine, London, United Kingdom
1 shared publication Francis Ndowa
1 shared publicationM Beksinksa
Reproductive Health and HIV Research Unit, Department of Obstetrics and Gynaecology, University of the Witwatersrand, South Africa, Suite 1301, Maritime House, 143 Salmon Grove, Durban, South Africa
1 shared publicationM Beksinska
Reproductive Health Research Unit, Durban, Suite 1301, Maritime House, Salmon Grove Durban, South Africa
1 shared publicationMarleen Temmerman
1 shared publication
Latest Publications
- Open Access
- 1 August 2005
- Published by BMJ in Sexually Transmitted Infections
- Vol. 81 (4) , 294-302
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries
Sexually transmitted infections (STIs) are common in the developing world. Management of STIs in pregnancy in many developing countries has, however, been complicated by the lack of simple and affordable diagnostic tests. This review examines the prevalence and impact on pregnancy outcome of STIs in developing countries and recommends approaches to management of STIs in pregnancy for resource poor settings.
- 1 August 2005
- Published by BMJ in Sexually Transmitted Infections
- Vol. 81 (4) , 294-302
Open AccessSexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries
Sexually transmitted infections (STIs) are common in the developing world. Management of STIs in pregnancy in many developing countries has, however, been complicated by the lack of simple and affordable diagnostic tests. This review examines the prevalence and impact on pregnancy outcome of STIs in developing countries and recommends approaches to management of STIs in pregnancy for resource poor settings.
- Open Access
- 1 June 2005
- Published by BMJ in Sexually Transmitted Infections
- Vol. 81 (3) , 220-222
Treatment for syphilis in antenatal care: compliance with the three dose standard treatment regimen
Background: In South Africa, three doses of benzathine penicillin 2.4 MU at weekly intervals are recommended for treating syphilis in pregnancy. Limited information is available on compliance with the recommended regimen, in terms of time to starting treatment, number of doses, and timing of treatment. Methods: The study was conducted to establish the degree of compliance with treatment for syphilis. Timing of treatment and the titres of the rapid plasma reagin (RPR) positive women were recorded. A retrospective record review was conducted of 18 128 antenatal records. These were records of women attending antenatal care clinics in a tertiary hospital catchment area in KwaZulu Natal between February 2001 and January 2002. Results: Treatment patterns showed that 15.9% received no treatment, 13.2% one dose, 5.8% received two doses, and 64.8% received three doses. In total, 188 women (1.03%) were found to be RPR positive. Of these 36% were found to be high titre positives (titre ⩾1:8). Conclusion: Completed treatment was significantly associated with age of gestation at first visit (p = 0.029), with women attending later in pregnancy less likely to receive all three doses of treatment.
- 1 June 2005
- Published by BMJ in Sexually Transmitted Infections
- Vol. 81 (3) , 220-222
Open AccessTreatment for syphilis in antenatal care: compliance with the three dose standard treatment regimen
Background: In South Africa, three doses of benzathine penicillin 2.4 MU at weekly intervals are recommended for treating syphilis in pregnancy. Limited information is available on compliance with the recommended regimen, in terms of time to starting treatment, number of doses, and timing of treatment. Methods: The study was conducted to establish the degree of compliance with treatment for syphilis. Timing of treatment and the titres of the rapid plasma reagin (RPR) positive women were recorded. A retrospective record review was conducted of 18 128 antenatal records. These were records of women attending antenatal care clinics in a tertiary hospital catchment area in KwaZulu Natal between February 2001 and January 2002. Results: Treatment patterns showed that 15.9% received no treatment, 13.2% one dose, 5.8% received two doses, and 64.8% received three doses. In total, 188 women (1.03%) were found to be RPR positive. Of these 36% were found to be high titre positives (titre ⩾1:8). Conclusion: Completed treatment was significantly associated with age of gestation at first visit (p = 0.029), with women attending later in pregnancy less likely to receive all three doses of treatment.